John Ballew

Search and Evaluation Lead, Oncology, Takeda Pharmaceuticals

2023 - Current

Academic Innovation Lead (Oncology), Takeda Pharmaceuticals

2021 - 2023

Sr Associate

2021 - 2021

Associate Director, R&D Business Development, Takeda Pharmaceuticals

2020 - 2021

Senior Manager, R&D Business Development, Takeda Pharmaceuticals

2019 - 2020

Senior Manager, Scientific & Competitive Analysis, Takeda Oncology

2018 - 2019

Manager, Scientific & Competitive Analysis, Takeda Oncology

2017 - 2018

Consultant

2017 - 2017

Life Sciences Consultant

2015 - 2016

VentureLabs Fellow

2015 - 2015

Postdoctoral Associate

2013 - 2015

Business Development Intern

2012 - 2013

• Performed market research and competitive intelligence in the areas of molecular diagnostics and biological therapeutics; reported to CTO on a weekly basis. • Assessed the funding and partnership/alliance landscape for ten biotechnology companies and developed basic financial forecasts using financial data for each company; evaluated biological therapeutic markets in numerous autoimmune disease franchises to support strategic-decision making in new disease area entry. • Conducted intellectual property searches to aid in applications development.

PhD, Biomolecular Science & Engineering

2006 - 2013

• Received degree in the UCSB Graduate Program in Management Practice, a business degree program designed to educate engineering-oriented PhD candidates in the areas of high-tech business management and entrepreneurship. • Completed two primary research studies on the development of antibody-based molecular diagnostics, resulting in one first author paper (PNAS) and co-first author paper (in submission); also published as contributing author (Nanotechnology for Chemical and Biological Defense). • A patent was filed and a start-up company was founded (Serimmune, Inc.) based on the PNAS paper methodology, 2014. • PNAS paper ranks in the top 5% of all articles ever tracked by Altmetric and currently ranks in the 98th percentile (out of 2,204,423 articles); PNAS research study was featured in two popular press articles in 2013. • Won Best Oral Presentation Award at the University of California Systemwide Bioengineering Symposium, 2013. • Awarded a Whitaker International Fellowship for Biomedical Engineers and studied at the Royal Institute of Technology in Stockholm, Sweden under Drs. Jochen Schwenk and Johan Rockberg (2010-2011). • Received 2010 UCSB Chang Fellowship for Outstanding Research in Biochemistry/Molecular Biology, 2 awarded in 2010. • Final GPA: 3.91/4.0

Visiting Research Scholar

2010 - 2011

Undergraduate Research Assistant

2004 - 2006

• Awarded consecutive annual Undergraduate Research Fellowships to fund primary research projects in the labs of Drs. John McDevitt and Jon Robertus, 2004 - 2006. • Nominated by faculty to serve as Undergraduate Research Journal Selection Board member, 25 students selected across UT Austin campus, 2005. • Elected to Marketing Director and Vice Presidential positions in the American Chemical Society affiliate chapter, 2003-2005. • UT Austin Arnold Beckman Scholarship Finalist, 2005.